Global Women’s Health Drugs Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Women’s Health Drugs Market Size 2017-2028

2.1.2 Women’s Health Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Women’s Health Drugs Segment by Type

2.2.1 EVISTA

2.2.2 XGEVA

2.2.3 Prolia

2.2.4 Mirena

2.2.5 Zometa

2.2.6 Reclast/Aclasta

2.2.7 Minastrin 24 Fe

2.2.8 Others (Premarin, ACTONEL, ORTHO TRI-CY LO)

2.3 Women’s Health Drugs Market Size by Type

2.3.1 Women’s Health Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Women’s Health Drugs Market Size Market Share by Type (2017-2022)

2.4 Women’s Health Drugs Segment by Application

2.4.1 Hormonal Infertility

2.4.2 Postmenopausal Osteoporosis

2.4.3 Endometriosis

2.4.4 Contraceptives

2.4.5 Menopause

2.4.6 Polycystic Ovary Syndrome

2.4.7 Other Applications

2.5 Women’s Health Drugs Market Size by Application

2.5.1 Women’s Health Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Women’s Health Drugs Market Size Market Share by Application (2017-2022)

3 Women’s Health Drugs Market Size by Player

3.1 Women’s Health Drugs Market Size Market Share by Players

3.1.1 Global Women’s Health Drugs Revenue by Players (2020-2022)

3.1.2 Global Women’s Health Drugs Revenue Market Share by Players (2020-2022)

3.2 Global Women’s Health Drugs Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Women’s Health Drugs by Regions

4.1 Women’s Health Drugs Market Size by Regions (2017-2022)

4.2 Americas Women’s Health Drugs Market Size Growth (2017-2022)

4.3 APAC Women’s Health Drugs Market Size Growth (2017-2022)

4.4 Europe Women’s Health Drugs Market Size Growth (2017-2022)

4.5 Middle East & Africa Women’s Health Drugs Market Size Growth (2017-2022)

5 Americas

5.1 Americas Women’s Health Drugs Market Size by Country (2017-2022)

5.2 Americas Women’s Health Drugs Market Size by Type (2017-2022)

5.3 Americas Women’s Health Drugs Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Women’s Health Drugs Market Size by Region (2017-2022)

6.2 APAC Women’s Health Drugs Market Size by Type (2017-2022)

6.3 APAC Women’s Health Drugs Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Women’s Health Drugs by Country (2017-2022)

7.2 Europe Women’s Health Drugs Market Size by Type (2017-2022)

7.3 Europe Women’s Health Drugs Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Women’s Health Drugs by Region (2017-2022)

8.2 Middle East & Africa Women’s Health Drugs Market Size by Type (2017-2022)

8.3 Middle East & Africa Women’s Health Drugs Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Women’s Health Drugs Market Forecast

10.1 Global Women’s Health Drugs Forecast by Regions (2023-2028)

10.1.1 Global Women’s Health Drugs Forecast by Regions (2023-2028)

10.1.2 Americas Women’s Health Drugs Forecast

10.1.3 APAC Women’s Health Drugs Forecast

10.1.4 Europe Women’s Health Drugs Forecast

10.1.5 Middle East & Africa Women’s Health Drugs Forecast

10.2 Americas Women’s Health Drugs Forecast by Country (2023-2028)

10.2.1 United States Women’s Health Drugs Market Forecast

10.2.2 Canada Women’s Health Drugs Market Forecast

10.2.3 Mexico Women’s Health Drugs Market Forecast

10.2.4 Brazil Women’s Health Drugs Market Forecast

10.3 APAC Women’s Health Drugs Forecast by Region (2023-2028)

10.3.1 China Women’s Health Drugs Market Forecast

10.3.2 Japan Women’s Health Drugs Market Forecast

10.3.3 Korea Women’s Health Drugs Market Forecast

10.3.4 Southeast Asia Women’s Health Drugs Market Forecast

10.3.5 India Women’s Health Drugs Market Forecast

10.3.6 Australia Women’s Health Drugs Market Forecast

10.4 Europe Women’s Health Drugs Forecast by Country (2023-2028)

10.4.1 Germany Women’s Health Drugs Market Forecast

10.4.2 France Women’s Health Drugs Market Forecast

10.4.3 UK Women’s Health Drugs Market Forecast

10.4.4 Italy Women’s Health Drugs Market Forecast

10.4.5 Russia Women’s Health Drugs Market Forecast

10.5 Middle East & Africa Women’s Health Drugs Forecast by Region (2023-2028)

10.5.1 Egypt Women’s Health Drugs Market Forecast

10.5.2 South Africa Women’s Health Drugs Market Forecast

10.5.3 Israel Women’s Health Drugs Market Forecast

10.5.4 Turkey Women’s Health Drugs Market Forecast

10.5.5 GCC Countries Women’s Health Drugs Market Forecast

10.6 Global Women’s Health Drugs Forecast by Type (2023-2028)

10.7 Global Women’s Health Drugs Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Bayer AG

11.1.1 Bayer AG Company Information

11.1.2 Bayer AG Women’s Health Drugs Product Offered

11.1.3 Bayer AG Women’s Health Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Bayer AG Main Business Overview

11.1.5 Bayer AG Latest Developments

11.2 Allergan

11.2.1 Allergan Company Information

11.2.2 Allergan Women’s Health Drugs Product Offered

11.2.3 Allergan Women’s Health Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Allergan Main Business Overview

11.2.5 Allergan Latest Developments

11.3 Merck & Co

11.3.1 Merck & Co Company Information

11.3.2 Merck & Co Women’s Health Drugs Product Offered

11.3.3 Merck & Co Women’s Health Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Merck & Co Main Business Overview

11.3.5 Merck & Co Latest Developments

11.4 Pfizer Inc

11.4.1 Pfizer Inc Company Information

11.4.2 Pfizer Inc Women’s Health Drugs Product Offered

11.4.3 Pfizer Inc Women’s Health Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Pfizer Inc Main Business Overview

11.4.5 Pfizer Inc Latest Developments

11.5 Amgen

11.5.1 Amgen Company Information

11.5.2 Amgen Women’s Health Drugs Product Offered

11.5.3 Amgen Women’s Health Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Amgen Main Business Overview

11.5.5 Amgen Latest Developments

11.6 Agile Therapeutics Inc

11.6.1 Agile Therapeutics Inc Company Information

11.6.2 Agile Therapeutics Inc Women’s Health Drugs Product Offered

11.6.3 Agile Therapeutics Inc Women’s Health Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Agile Therapeutics Inc Main Business Overview

11.6.5 Agile Therapeutics Inc Latest Developments

11.7 Ferring Pharmaceuticals

11.7.1 Ferring Pharmaceuticals Company Information

11.7.2 Ferring Pharmaceuticals Women’s Health Drugs Product Offered

11.7.3 Ferring Pharmaceuticals Women’s Health Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Ferring Pharmaceuticals Main Business Overview

11.7.5 Ferring Pharmaceuticals Latest Developments

11.8 Mylan N.V.

11.8.1 Mylan N.V. Company Information

11.8.2 Mylan N.V. Women’s Health Drugs Product Offered

11.8.3 Mylan N.V. Women’s Health Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Mylan N.V. Main Business Overview

11.8.5 Mylan N.V. Latest Developments

11.9 Lupin (India)

11.9.1 Lupin (India) Company Information

11.9.2 Lupin (India) Women’s Health Drugs Product Offered

11.9.3 Lupin (India) Women’s Health Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Lupin (India) Main Business Overview

11.9.5 Lupin (India) Latest Developments

11.10 Eli Lilly And Company

11.10.1 Eli Lilly And Company Company Information

11.10.2 Eli Lilly And Company Women’s Health Drugs Product Offered

11.10.3 Eli Lilly And Company Women’s Health Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Eli Lilly And Company Main Business Overview

11.10.5 Eli Lilly And Company Latest Developments

11.11 Novartis AG

11.11.1 Novartis AG Company Information

11.11.2 Novartis AG Women’s Health Drugs Product Offered

11.11.3 Novartis AG Women’s Health Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Novartis AG Main Business Overview

11.11.5 Novartis AG Latest Developments

11.12 Johnson & Johnson

11.12.1 Johnson & Johnson Company Information

11.12.2 Johnson & Johnson Women’s Health Drugs Product Offered

11.12.3 Johnson & Johnson Women’s Health Drugs Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Johnson & Johnson Main Business Overview

11.12.5 Johnson & Johnson Latest Developments

12 Research Findings and Conclusion

Table 1. Women’s Health Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of EVISTA

Table 3. Major Players of XGEVA

Table 4. Major Players of Prolia

Table 5. Major Players of Mirena

Table 6. Major Players of Zometa

Table 7. Major Players of Reclast/Aclasta

Table 8. Major Players of Minastrin 24 Fe

Table 9. Major Players of Others (Premarin, ACTONEL, ORTHO TRI-CY LO)

Table 10. Women’s Health Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Women’s Health Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 12. Global Women’s Health Drugs Market Size Market Share by Type (2017-2022)

Table 13. Women’s Health Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 14. Global Women’s Health Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 15. Global Women’s Health Drugs Market Size Market Share by Application (2017-2022)

Table 16. Global Women’s Health Drugs Revenue by Players (2020-2022) & ($ Millions)

Table 17. Global Women’s Health Drugs Revenue Market Share by Player (2020-2022)

Table 18. Women’s Health Drugs Key Players Head office and Products Offered

Table 19. Women’s Health Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 20. New Products and Potential Entrants

Table 21. Mergers & Acquisitions, Expansion

Table 22. Global Women’s Health Drugs Market Size by Regions 2017-2022 & ($ Millions)

Table 23. Global Women’s Health Drugs Market Size Market Share by Regions (2017-2022)

Table 24. Americas Women’s Health Drugs Market Size by Country (2017-2022) & ($ Millions)

Table 25. Americas Women’s Health Drugs Market Size Market Share by Country (2017-2022)

Table 26. Americas Women’s Health Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 27. Americas Women’s Health Drugs Market Size Market Share by Type (2017-2022)

Table 28. Americas Women’s Health Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 29. Americas Women’s Health Drugs Market Size Market Share by Application (2017-2022)

Table 30. APAC Women’s Health Drugs Market Size by Region (2017-2022) & ($ Millions)

Table 31. APAC Women’s Health Drugs Market Size Market Share by Region (2017-2022)

Table 32. APAC Women’s Health Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 33. APAC Women’s Health Drugs Market Size Market Share by Type (2017-2022)

Table 34. APAC Women’s Health Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 35. APAC Women’s Health Drugs Market Size Market Share by Application (2017-2022)

Table 36. Europe Women’s Health Drugs Market Size by Country (2017-2022) & ($ Millions)

Table 37. Europe Women’s Health Drugs Market Size Market Share by Country (2017-2022)

Table 38. Europe Women’s Health Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 39. Europe Women’s Health Drugs Market Size Market Share by Type (2017-2022)

Table 40. Europe Women’s Health Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 41. Europe Women’s Health Drugs Market Size Market Share by Application (2017-2022)

Table 42. Middle East & Africa Women’s Health Drugs Market Size by Region (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Women’s Health Drugs Market Size Market Share by Region (2017-2022)

Table 44. Middle East & Africa Women’s Health Drugs Market Size by Type (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Women’s Health Drugs Market Size Market Share by Type (2017-2022)

Table 46. Middle East & Africa Women’s Health Drugs Market Size by Application (2017-2022) & ($ Millions)

Table 47. Middle East & Africa Women’s Health Drugs Market Size Market Share by Application (2017-2022)

Table 48. Key Market Drivers & Growth Opportunities of Women’s Health Drugs

Table 49. Key Market Challenges & Risks of Women’s Health Drugs

Table 50. Key Industry Trends of Women’s Health Drugs

Table 51. Global Women’s Health Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 52. Global Women’s Health Drugs Market Size Market Share Forecast by Regions (2023-2028)

Table 53. Global Women’s Health Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 54. Global Women’s Health Drugs Market Size Market Share Forecast by Type (2023-2028)

Table 55. Global Women’s Health Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 56. Global Women’s Health Drugs Market Size Market Share Forecast by Application (2023-2028)

Table 57. Bayer AG Details, Company Type, Women’s Health Drugs Area Served and Its Competitors

Table 58. Bayer AG Women’s Health Drugs Product Offered

Table 59. Bayer AG Women’s Health Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Bayer AG Main Business

Table 61. Bayer AG Latest Developments

Table 62. Allergan Details, Company Type, Women’s Health Drugs Area Served and Its Competitors

Table 63. Allergan Women’s Health Drugs Product Offered

Table 64. Allergan Main Business

Table 65. Allergan Women’s Health Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Allergan Latest Developments

Table 67. Merck & Co Details, Company Type, Women’s Health Drugs Area Served and Its Competitors

Table 68. Merck & Co Women’s Health Drugs Product Offered

Table 69. Merck & Co Main Business

Table 70. Merck & Co Women’s Health Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Merck & Co Latest Developments

Table 72. Pfizer Inc Details, Company Type, Women’s Health Drugs Area Served and Its Competitors

Table 73. Pfizer Inc Women’s Health Drugs Product Offered

Table 74. Pfizer Inc Main Business

Table 75. Pfizer Inc Women’s Health Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Pfizer Inc Latest Developments

Table 77. Amgen Details, Company Type, Women’s Health Drugs Area Served and Its Competitors

Table 78. Amgen Women’s Health Drugs Product Offered

Table 79. Amgen Main Business

Table 80. Amgen Women’s Health Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Amgen Latest Developments

Table 82. Agile Therapeutics Inc Details, Company Type, Women’s Health Drugs Area Served and Its Competitors

Table 83. Agile Therapeutics Inc Women’s Health Drugs Product Offered

Table 84. Agile Therapeutics Inc Main Business

Table 85. Agile Therapeutics Inc Women’s Health Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Agile Therapeutics Inc Latest Developments

Table 87. Ferring Pharmaceuticals Details, Company Type, Women’s Health Drugs Area Served and Its Competitors

Table 88. Ferring Pharmaceuticals Women’s Health Drugs Product Offered

Table 89. Ferring Pharmaceuticals Main Business

Table 90. Ferring Pharmaceuticals Women’s Health Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Ferring Pharmaceuticals Latest Developments

Table 92. Mylan N.V. Details, Company Type, Women’s Health Drugs Area Served and Its Competitors

Table 93. Mylan N.V. Women’s Health Drugs Product Offered

Table 94. Mylan N.V. Main Business

Table 95. Mylan N.V. Women’s Health Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Mylan N.V. Latest Developments

Table 97. Lupin (India) Details, Company Type, Women’s Health Drugs Area Served and Its Competitors

Table 98. Lupin (India) Women’s Health Drugs Product Offered

Table 99. Lupin (India) Main Business

Table 100. Lupin (India) Women’s Health Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Lupin (India) Latest Developments

Table 102. Eli Lilly And Company Details, Company Type, Women’s Health Drugs Area Served and Its Competitors

Table 103. Eli Lilly And Company Women’s Health Drugs Product Offered

Table 104. Eli Lilly And Company Main Business

Table 105. Eli Lilly And Company Women’s Health Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Eli Lilly And Company Latest Developments

Table 107. Novartis AG Details, Company Type, Women’s Health Drugs Area Served and Its Competitors

Table 108. Novartis AG Women’s Health Drugs Product Offered

Table 109. Novartis AG Women’s Health Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Novartis AG Main Business

Table 111. Novartis AG Latest Developments

Table 112. Johnson & Johnson Details, Company Type, Women’s Health Drugs Area Served and Its Competitors

Table 113. Johnson & Johnson Women’s Health Drugs Product Offered

Table 114. Johnson & Johnson Main Business

Table 115. Johnson & Johnson Women’s Health Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. Johnson & Johnson Latest Developments

List of Figures

Figure 1. Women’s Health Drugs Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Women’s Health Drugs Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Women’s Health Drugs Market Size Market Share by Type in 2021

Figure 7. Women’s Health Drugs in Hormonal Infertility

Figure 8. Global Women’s Health Drugs Market: Hormonal Infertility (2017-2022) & ($ Millions)

Figure 9. Women’s Health Drugs in Postmenopausal Osteoporosis

Figure 10. Global Women’s Health Drugs Market: Postmenopausal Osteoporosis (2017-2022) & ($ Millions)

Figure 11. Women’s Health Drugs in Endometriosis

Figure 12. Global Women’s Health Drugs Market: Endometriosis (2017-2022) & ($ Millions)

Figure 13. Women’s Health Drugs in Contraceptives

Figure 14. Global Women’s Health Drugs Market: Contraceptives (2017-2022) & ($ Millions)

Figure 15. Women’s Health Drugs in Menopause

Figure 16. Global Women’s Health Drugs Market: Menopause (2017-2022) & ($ Millions)

Figure 17. Women’s Health Drugs in Polycystic Ovary Syndrome

Figure 18. Global Women’s Health Drugs Market: Polycystic Ovary Syndrome (2017-2022) & ($ Millions)

Figure 19. Women’s Health Drugs in Other Applications

Figure 20. Global Women’s Health Drugs Market: Other Applications (2017-2022) & ($ Millions)

Figure 21. Global Women’s Health Drugs Market Size Market Share by Application in 2021

Figure 22. Global Women’s Health Drugs Revenue Market Share by Player in 2021

Figure 23. Global Women’s Health Drugs Market Size Market Share by Regions (2017-2022)

Figure 24. Americas Women’s Health Drugs Market Size 2017-2022 ($ Millions)

Figure 25. APAC Women’s Health Drugs Market Size 2017-2022 ($ Millions)

Figure 26. Europe Women’s Health Drugs Market Size 2017-2022 ($ Millions)

Figure 27. Middle East & Africa Women’s Health Drugs Market Size 2017-2022 ($ Millions)

Figure 28. Americas Women’s Health Drugs Value Market Share by Country in 2021

Figure 29. Americas Women’s Health Drugs Consumption Market Share by Type in 2021

Figure 30. Americas Women’s Health Drugs Market Size Market Share by Application in 2021

Figure 31. United States Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 32. Canada Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 33. Mexico Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 34. Brazil Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 35. APAC Women’s Health Drugs Market Size Market Share by Region in 2021

Figure 36. APAC Women’s Health Drugs Market Size Market Share by Application in 2021

Figure 37. China Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 38. Japan Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 39. Korea Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 40. Southeast Asia Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 41. India Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 42. Australia Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 43. Europe Women’s Health Drugs Market Size Market Share by Country in 2021

Figure 44. Europe Women’s Health Drugs Market Size Market Share by Type in 2021

Figure 45. Europe Women’s Health Drugs Market Size Market Share by Application in 2021

Figure 46. Germany Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 47. France Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 48. UK Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 49. Italy Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 50. Russia Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 51. Middle East & Africa Women’s Health Drugs Market Size Market Share by Region in 2021

Figure 52. Middle East & Africa Women’s Health Drugs Market Size Market Share by Type in 2021

Figure 53. Middle East & Africa Women’s Health Drugs Market Size Market Share by Application in 2021

Figure 54. Egypt Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 55. South Africa Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 56. Israel Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 57. Turkey Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 58. GCC Country Women’s Health Drugs Market Size Growth 2017-2022 ($ Millions)

Figure 59. Americas Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 60. APAC Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 61. Europe Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 62. Middle East & Africa Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 63. United States Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 64. Canada Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 65. Mexico Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 66. Brazil Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 67. China Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 68. Japan Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 69. Korea Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 70. Southeast Asia Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 71. India Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 72. Australia Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 73. Germany Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 74. France Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 75. UK Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 76. Italy Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 77. Russia Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 78. Spain Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 79. Egypt Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 80. South Africa Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 81. Israel Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 82. Turkey Women’s Health Drugs Market Size 2023-2028 ($ Millions)

Figure 83. GCC Countries Women’s Health Drugs Market Size 2023-2028 ($ Millions)